Aytu biopharma to present at lytham partners investor select conference on january 31

Englewood, co / accesswire / january 24, 2023 / aytu biopharma, inc. (the company or "aytu") (nasdaq:aytu), a commercial stage pharmaceutical and consumer health company providing pediatric-focused prescription drugs and cost-effective consumer health solutions, today announced that josh disbrow, chief executive officer, will present and host one-on-one meetings with investors at the lytham partners investor select conference, taking place virtually on january 31, 2023. company webcast the company's webcast presentation will be available for viewing at 9:00 am et on tuesday, january 31, 2023, on the company's website at https://irdirect.net/aytu or at https://wsw.com/webcast/lytham7/aytu/2069810.
AYTU Ratings Summary
AYTU Quant Ranking